Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Investor call/earning call held on February 17, 2023.22-02-2023
22-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Outcome of quarterly Investor Con. call held on February 17, 202317-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Presentation - February 17, 202317-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of the Investor Conference call.14-02-2023
Orchid Pharma back in green after many quarters; posts Q3 net of 6.73 crore
Consolidated revenue from operations was marginally down to 159.76 crore10-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication10-02-2023
Orchid Pharma Ltd - 524372 - Approved Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended December 31, 2022.
Approved Un-Audited Financial Results (Standalone & Consolidated) for quarter ended December 31, 2022.09-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.09-02-2023
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for To Approve Financial Result (Standalone And Consolidated) For The Quarter Ended December 31, 2022
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve To approve Financial Result (Standalone and Consolidated) for the quarter ended December 31, 202203-02-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Change in Management
Disclosure under Regulation 30 of SEBI(LODR) Regulation, 2015 -Demise of Director.01-02-2023